Please ensure Javascript is enabled for purposes of website accessibility

UCR School of Medicine to Serve as Lead Site for Clinical Trial on Stuttering

UCR School of Medicine to serve as lead site for clinical trial on stuttering.   

The School of Medicine at the University of California, Riverside, will serve as lead site for a Phase 2 clinical trial evaluating ecopipam, an investigational first-in-class drug being tested for the treatment of stuttering in adults and Tourette syndrome in pediatric patients.  

Find the full article here: Emalex news release written by Evelyn M. O’Connor. 

Aviso de Prácticas de Privacidad

Este sitio utiliza cookies para mejorar sus experiencias. Descarte para continuar o haga clic para obtener más información sobre nuestro Aviso de prácticas de privacidad.

Leer Mas
Aviso de Prácticas de Privacidad